Dr. Elmunzer reviewing information with another physician

Member Directory

Center Member Department Research Description
Peggi M. Angel, Ph.D. Cell and Molecular Pharmacology and Experimental Therapeutics MS-analysis of extracellular matrix in liver disease
Tim Barnoud, Ph.D. Biochemistry and Molecular Biology
Heat shock proteins and p53 variants in cancer risk
Katherine E. Chetta, M.D. Pediatrics HAMLET and oleic acid in preterm intestinal disease
Toros Dincman, M.D., Ph.D. Hematology/Oncology Genomic, transcriptional and post-transcriptional mechanisms in tumorigenesis
Richard R. Drake, Ph.D. Cell & Molecular Pharmacology MS approaches for glycan and glycoprotein markers of GI disease
Stephen A. Duncan, DPhil Regenerative Medicine & Cell Biology iPSC hepatocyte modeling of metabolic liver disease
Valerie Durkalski-Mauldin, M.P.H., Ph.D. Public Health Sciences Clinical trial methodology and implementation, digestive diseases
Badih J. Elmunzer, M.D., MSc Medicine GI endoscopy, ERCP, colorectal cancer screening
Amy C. Engevik, Ph.D. Regenerative Medicine & Cell Biology  Microvillus Inclusion Disease (MVID) and cholestasis
Mindy A. Engevik, Ph.D. Regenerative Medicine & Cell Biology  Microbial-host crosstalk in the intestinal mucus layer
Lewis J. Frey, Ph.D. Public Health Sciences Artificial Intelligence approaches for modeling liver disease
Wenjian Gan, Ph.D. Biochemistry and Molecular Biology Kinase pathways in liver disease and cancer
Silvia Guglietta, Ph.D. Microbiology and Immunology Complement factor impact on immune response and gut microbiota in IBD
Denis C. Guttridge, Ph.D. Pediatrics Pancreatic cancer and cachexia
Jessica H. Hartman, Ph.D. Biochemistry and Molecular Biology Metabolism and xenobiotic and mechanistic toxicology in liver disease
Jessica Hathaway-Schrader, Ph.D. Pathology & Laboratory Medicine Role of complement signaling and commensal flora in skeletal development
Aaron Hobbs, Ph.D. Pharmacology Ras mutations in pancreatic cancer
Antonis Kourtidis, Ph.D. Regenerative Medicine & Cell Biology RNAi regulation at colonic epithelial cell junctions
John J. Lemasters, M.D., Ph.D. Drug Discovery & Biomedical Sciences Mitochondria in ethanol and drug-induced liver injury
Anand S. Mehta, Ph.D. Cell & Molecular Pharmacology Glycoproteomics in liver cancer
Eric G. Meissner, M.D., Ph.D. Medicine Hepatitis C viral infection
Jorge Múnera, Ph.D. Regenerative Medicine and Cell Biology iPSC colonic organoids for modeling GI disease
Anna-Liisa Nieminen, Ph.D. Drug Discovery & Biomedical Sciences Iron homeostasis and liver injury
Paul J. Nietert, Ph.D. Public Health Sciences Hierarchical data analysis, truncated distributions, randomization in clinical trials
John P. O'Bryan, Ph.D. Cellular and Molecular Pharmacology Therapeutics targeting RAS function in GI cancer
Don C. Rockey, M.D. Medicine Liver fibrosis and portal hypertension
Natalie Saini, Ph.D. Biochemistry and Molecular Biology Environmental exposures in HCC
Andrew D. Schreiner, MD, MSCR  Medicine EHR-based primary care management of chronic liver disease
Garth R. Swanson, M.D. Medicine Circadian rhythm and IBD
Chenthamarakshan Vasu, Ph.D. Microbiology & Immunology Mucosal-microbiota-dietary interactions in colitis
Dirk J. van der Windt, M.D., Ph.D. Surgery Mechanisms of inflammation and injury in liver transplantation
Kristin Wallace, Ph.D. Public Health Sciences Racial disparities in colorectal cancer
Hongjun Wang, Ph.D. Surgery Novel therapeutics for chronic pancreatitis
Caroline Westwater, Ph.D.
Microbiology & Immunology  Candida infections in GI disease
Yuan Zhai, M.D., Ph.D. Surgery Ischemia/reperfusion injury in liver transplantaton
Zhi Zhong, M.D., Ph.D. Drug Discovery & Biomedical Sciences Targeting mitochondrial dysfunction in liver disease